Evidence map›Paper›PMID 32602642›Full record

ArticleJournal of the International AIDS Society2020

Disparities in the PrEP continuum for trans women compared to MSM in San Francisco, California: results from population-based cross-sectional behavioural surveillance studies.

Erin C Wilson, Caitlin M Turner, Sean Arayasirikul, Marguerita Lightfoot, Susan Scheer, Henry F Raymond, Albert Liu

Open access · goldAbstract readComparative Study
In one paragraph

Article in Journal of the International AIDS Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Erin C WilsonCenter for Public Health Research, San Francisco Department of Public Health, San Francisco, CA, USA.ORCID 0000-0002-0237-495X
Caitlin M TurnerCenter for Public Health Research, San Francisco Department of Public Health, San Francisco, CA, USA.
Sean ArayasirikulCenter for Public Health Research, San Francisco Department of Public Health, San Francisco, CA, USA.
Marguerita LightfootDivision of Prevention Science, Center for AIDS Prevention Studies, University of California, San Francisco, CA, USA.
Susan ScheerHIV Epidemiology, San Francisco Department of Public Health, San Francisco, CA, USA.
Henry F RaymondRutgers University, New Jersey, USA.
Albert LiuBridge HIV, San Francisco Department of Public Health, San Francisco, CA, USA.
San Francisco Department of Public Health · USRutgers, The State University of New Jersey · USUniversity of California, San Francisco · US

Funding

Ujima Mentoring ProgramP30MH062246 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MALLORY O JOHNSON · 2001 to 2026
$57.4M
The Transnational Cohort: global HIV epidemiology and prevention research for transwomen.R01MD010678 · NIMHD · PUBLIC HEALTH FOUNDATION ENTERPRISES · PI MCFARLAND, WILLIAM, MEEK, ERIN CATHERINE · 2015 to 2019
$2.4M
NIMHD NIH HHS R01 MD010678NIMH NIH HHS P30 MH062246NIMH NIH HHS P30MH062246
6 · The paper itself

Abstract

introductionAlthough transgender women (trans women) often are conflated with men who have sex with men  (MSM) in HIV research and services, there are distinct population differences that are important for implementing effective HIV prevention. Our objective was to examine pre-exposure prophylaxis (PrEP) disparities between the two populations and compare individual, social and structural factors that influence differences between MSM and trans women along the PrEP continuum.

methodsWe analysed data from two population-based studies, one with trans women (Trans*National Study, 2016 - 18) and the other with MSM (National HIV Behavioral Surveillance, 2017). Trans women were recruited via respondent-driven sampling and MSM using time location sampling. Key indicators of the PrEP continuum were evaluated, including awareness, health insurance, provider discussions, recent use and adherence. Associations were also examined for PrEP continuum indicators and structural barriers (e.g. employment, homelessness).

resultsTranswomen were more likely than MSM to be Latino/a (30.4% vs. 25.8%; prevalence ratio (PR)=1.08, 95% CI 1.02 to 1.14) or African American (7.1% vs. 4.5%; PR = 1.12, 1.02 to 1.24), live at or below the poverty limit (70.7% vs. 15.8%; PR = 1.47; 1.41 to 1.53), be unemployed (50.1% vs. 26.3%; PR = 1.18, 1.13 to 1.24), be homeless (8.4% vs. 3.5%; PR = 1.15, 1.06 to 1.25) and to have less than a college degree (PR = 1.41, 1.34 to 1.48). Trans women were more likely than MSM to have health insurance (95.7% vs. 89.7%, PR = 1.17, 1.06 to 1.28), but less likely than MSM to have heard of PrEP (79.1% vs. 96.7%; PR = 0.77, 0.73 to 0.81), talked with a provider about PrEP (35.5% vs. 54.9%; PR = 0.87, 0.83 to 0.91) and less likely than MSM to have used PrEP in the past six months (14.6% vs. 39.8%; PR = 0.80, 0.76 to 0.84). Among PrEP users, trans women were less likely to report being adherent to PrEP than MSM (70.4% vs. 87.4%; PR = 0.80, 0.70 to 0.91).

conclusionsWe found PrEP disparities for trans women compared to MSM and the need for differentiated implementation strategies to meet the specific PrEP barriers trans women face. Inclusion of trans women's HIV risks is needed in CDC guidance for PrEP. Interventions to increase trans women's awareness of PrEP including at the provider and community level are also needed. Finally, programming that addresses trans women's barriers to housing and income is also needed to reduce PrEP disparities.

Indexed as

Pre-Exposure ProphylaxisSexual and Gender MinoritiesSexual BehaviorTransgender PersonsAdultAnti-HIV AgentsBlack or African AmericanContinuity of Patient CareCross-Sectional StudiesFemaleGender IdentityHispanic or LatinoHIV InfectionsHomosexuality, MaleHumansMaleAnti-HIV AgentsdisparitiesHIVpre-exposure prophylaxisPrEPtransgender women

Identifiers

PMID32602642
PMCPMC7325513
OpenAlexW3038667400

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.